ArticleCureus2026
Primary Apocrine Adenocarcinoma of the Vulva: A Report of a Rare Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary apocrine adenocarcinoma of the vulva is a rare and aggressive malignancy that typically presents as an irregular vulvar lesion with associated dermatologic changes. Diagnosis can be challenging due to significant clinical and histopathologic overlap with other vulvar adenocarcinomas as well as metastatic disease. We present the case of a 63-year-old postmenopausal woman diagnosed with primary apocrine adenocarcinoma of the vulva. The patient's prior history of breast cancer created a diagnostic dilemma, as it was initially unclear whether the lesion represented metastatic breast carcinoma or a primary vulvar malignancy. Histopathologic evaluation with immunohistochemical analysis demonstrated strong androgen receptor positivity, negative estrogen receptor and progesterone receptor staining, strong GCDFP-15 positivity, and strong CK7 positivity. This profile supported the diagnosis of primary vulvar apocrine adenocarcinoma, allowing for appropriate surgical management and successful excision of the lesion. This case highlights the diagnostic complexity of vulvar adenocarcinomas and underscores the importance of systematic clinicopathologic evaluation, particularly in patients with a history of malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.